FTC Questions Academics' Interest In Backing Illumina
Federal Trade Commission staffers want a group of antitrust, patent and economics academics barred from backing DNA sequencing company Illumina's $8 billion reacquisition of Grail against an agency in-house merger challenge, suggesting...To view the full article, register now.
Already a subscriber? Click here to view full article